Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure

Overview of attention for article published in FASEB Journal, August 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent: 8 patents

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Methods and materials for gender-dependent treatment of cardiovascular dysfunction

Grant US-12465605-B2

United States of America

11 Nov 2025

Methods and materials for treating calcific aortic valve stenosis

Grant US-11197871-B2

United States of America

14 Dec 2021

METHODS AND MATERIALS FOR GENDER-DEPENDENT TREATMENT OF CARDIOVASCULAR DYSFUNCTION

Application WO-2020210707-A1

World Intellectual Property Organisation (WIPO)

15 Oct 2020

Methods and materials for treating calcific aortic valve stenosis

Grant US-10568895-B2

United States of America

25 Feb 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.